|
TERN
|
Terns Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
SPRY
|
ARS Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
SMMT
|
Summit Therapeutics plc
|
0.01%
|
US
|
NASDAQ
|
|
SELB
|
Selecta Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
0.01%
|
US
|
NASDAQ
|
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
OMGA
|
Omega Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
NAUT
|
Nautilus Biotechnology, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
KNTE
|
Kinnate Biopharma Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMRX
|
Immuneering Corporation
|
0.01%
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GRNA
|
GreenLight Biosciences Holdings, PBC
|
0.01%
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
FHTX
|
Foghorn Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
|
EVLO
|
Evelo Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
0.01%
|
US
|
NASDAQ
|
|
AUTL
|
Autolus Therapeutics plc
|
0.01%
|
US
|
NASDAQ
|